Hetero Drugs Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Hetero Drugs Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					         Hetero Drugs Limited - Pharmaceuticals & Healthcare - Deals and Alliances
                                         Profile
       Reference Code: GDPH81515D                                                                                                               Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Hetero drugs Limited (Hetero) is a private pharmaceutical company based in India.
                                                                                                              Hetero Drugs Limited, Pharmaceuticals &
      The company manufactures active pharmaceutical ingredients and finished dosage
                                                                                                              Healthcare, Key Facts
      forms. It provides about 200 products from wide range of therapeutic categories both
      in active pharmaceutical ingredients and finished dosages. The manufacturing                             Web Address                            www.heterodrugs.com
      facilities of Hetero are cGMP compliant meeting global standards in terms of
                                                                                                               Revenue (US$ million)                                 NA
      infrastructure and systems. The products of the company are approved by the
      various regulatory authorities of USFDA, WHO-Geneva, Australian TGA, Spanish                             Number of Employees                                   NA
      agency of medicines & health care products, ANVISA-Brazil and IDA-Netherlands.                           GlobalData
      The Formulation Facilities of the company include, Hetero Drugs Ltd.

      Financial Deals Landscape
        Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals by                      Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                                                      2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                                                           1
                                                                                                          1


                                                                                                                 0         0       0        0                         0
                                                                                                          0
                                                                                                               2007       2008   2009      2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals                        Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013


                                  2             2                                                                     3
                                                                                                          3
                                                                                           No. of Deals




                         2
          No. of Deals




                                                                                                          2
                                                                                                                                       1          1              1
                         1
                                                                                                          1


                                                                0                                         0
                         0                                                                                       Infectiou       Cardiova       Central   Gastroint
                             Asia-Pacific   Middle East      North                                               s Disease        scular        Nervous    estinal
                                            and Africa      America                                                                             System



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Hetero Drugs Limited - Pharmaceuticals & Healthcare - Deals and                                                                                    Reference Code: GDPH81515D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013................................................................ 3
       Hetero Drugs Limited, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................ 5
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 6
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013.................................................. 7
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................................. 8
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deal Details .................................................................................................. 9
          Partnerships.................................................................................................................................................................................... 9
             Hetero Drugs Forms Joint Venture With Neopharma .................................................................................................................. 9
          Licensing Agreements .................................................................................................................................................................. 10
             Gilead Sciences Extends Licensing Agreement With Hetero Drugs For Tenofovir, Elvitegravir, Cobicistat And Quad ............. 10
             Tibotec Pharma Enters Into Licensing Agreement With Hetero Drugs For TMC278 ................................................................. 12
       Hetero Drugs Limited - Key Competitors .......................................................................................................................................... 13
       Key Employees ................................................................................................................................................................................ 14
       Locations And Subsidiaries .............................................................................................................................................................. 15
          Head Office ................................................................................................................................................................................... 15
       Appendix .......................................................................................................................................................................................... 16
          Methodology ................................................................................................................................................................................. 16
          About GlobalData ......................................................................................................................................................................... 16
          Contact Us .................................................................................................................................................................................... 16
          Disclaimer ..................................................................................................................................................................................... 16




Hetero Drugs Limited - Pharmaceuticals & Healthcare - Deals and                                                                                                    Reference Code: GDPH81515D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Key Facts...................................................................................................... 1
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013................................................................ 1
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 1
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013.................................................. 1
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013................................................................ 4
       Hetero Drugs Limited, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................ 5
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 6
       Hetero Drugs Limited, Deals By Therapy Area, 2007 to YTD 2013.................................................................................................... 7
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................................. 8
       Hetero Drugs Forms Joint Venture With Neopharma ......................................................................................................................... 9
       Gilead Sciences Extends Licensing Agreement With Hetero Drugs For Tenofovir, Elvitegravir, Cobicistat And Quad .................... 10
       Tibotec Pharma Enters Into Licensing Agreement With Hetero Drugs For TMC278 ........................................................................ 12
       Hetero Drugs Limited, Key Competitors ........................................................................................................................................... 13
       Hetero Drugs Limited, Key Employees ............................................................................................................................................. 14


       List of Figures
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013................................................................ 1
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013................................................................ 4
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013................................................................ 5
       Hetero Drugs Limited, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 6
       
				
DOCUMENT INFO
Description: Hetero drugs Limited (Hetero) is a private pharmaceutical company based in India. The company manufactures active pharmaceutical ingredients and finished dosage forms. It provides about 200 products from wide range of therapeutic categories both in active pharmaceutical ingredients and finished dosages. The manufacturing facilities of Hetero are cGMP compliant meeting global standards in terms of infrastructure and systems. The products of the company are approved by the various regulatory authorities of USFDA, WHO-Geneva, Australian TGA, Spanish agency of medicines & health care products, ANVISA-Brazil and IDA-Netherlands. The Formulation Facilities of the company include, Hetero Drugs Ltd., Hetero Labs Ltd. and Invagen Pharmaceuticals Inc., USA. Hetero is headquartered in Andhra Pradesh, Hyderabad, India.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.